Kishore Kumar Meenakshi Sundaram

Kishore Kumar Meenakshi Sundaram

Auto-generated profile, based on publicly available information

Kishore Kumar Meenakshi Sundaram

Department of Anatomy, Saveetha Institute of Medical and Technical Sciences, India

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2023 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
RCRajkuberan Chandrasekaran
Rajkuberan Chandrasekaran
MKMuthukumar Krishnan
Muthukumar Krishnan
GBGiridharan Bupesh
Giridharan Bupesh
SCSonu Chacko
Sonu Chacko
OGOmkar Gawade
Omkar Gawade
SSSuresh Sagadevan
Suresh Sagadevan

27 May 2022 in Journal of Pure and Applied Microbiology
Verified
Journal Article
Open access
ABApb Balaji
Apb Balaji
SBSrinivasan Bhuvaneswari
Srinivasan Bhuvaneswari
LTLeon Stephan Stephan Raj T
Leon Stephan Stephan Raj T
GBGiridharan Bupesh
Giridharan Bupesh
KMKishore Kumar Meenakshisundaram
Kishore Kumar Meenakshisundaram
Konda Mani SaravananKonda Mani Saravanan
Konda Mani Saravanan
Natural products are a great wellspring of biodiversity for finding novel antivirals, exposing new interactions between structure and operation and creating successful defensive or remedial methodologies against viral diseases. The members of Zingiberaceae traditional plant and herbal products have robust anti-viral action, and their findings will further lead to the production of derivatives and therapeutic. Additionally, it highlights the insight of utilizing these phytoextracts or their constituent compounds as an emergency prophylactic medicine during the pandemic or endemic situations for novel viruses. In this connection, this review investigates the potential candidates of the Zingiberaceae family, consisting of bioactive phytocompounds with proven antiviral efficacy against enveloped viruses. The present study was based on published antiviral efficacy of Curcuma longa, Zingiber officinale, Kaempferia parviflora, Aframomum melegueta Elettaria cardamomum, Alpina Sps (belongs to the Zingiberaceae family) towards the enveloped viruses. The relevant data was searched in Scopus”, “Scifinder”, “Springer”, “Pubmed”, “Google scholar” “Wiley”, “Web of Science”, “Cochrane “Library”, “Embase”, Dissertations, theses, books, and technical reports. Meticulously articles were screened with the subject relevancy and categorized for their ethnopharmacological significance with in-depth analysis. We have comprehensively elucidated the antiviral potency of phytoextracts, major composition, key compounds, mode of action, molecular evidence, immunological relevance, and potential bioactive phytocompounds of these five species belonging to the Zingiberaceae family. Conveniently, these phytoextracts exhibited multimode activity in combating the dreadful enveloped viruses.

1 October 2022 in Coronaviruses
Verified
Journal Article
Closed access
PDF file
GBGiridharan Bupesh
Giridharan Bupesh
Konda Mani SaravananKonda Mani Saravanan
Konda Mani Saravanan
KSKishore Kumar Meenakshi Sundaram
Kishore Kumar Meenakshi Sundaram
AKAttuluri Vamsi Kumar
Attuluri Vamsi Kumar
TAThomas Alphonsa
Thomas Alphonsa
PBPranjal Bharali
Pranjal Bharali
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) has caused a global human outbreak, making it a more serious threat to human health than any other infectious disease. Coronavirus infectious disease 2019 (COVID-19) has severely affected the lifestyles of people around the world and caused high mortality throughout the world. In both pandemic and seasonal influenza, co-infection of COVID-19 with other diseases has been linked to worse outcomes. The literature revealed that it is characteristically associated with comorbidities such as hypertension, blood pressure, obesity, cardiovascular diseases, and other microbial infections. Furthermore, microbial coinfections worsen respiratory viral infections and are a common cause of death in influenza pandemics. Deplorably, Tuberculosis (TB) is also a dreadful lung infection and attains cytokine equilibrium with host cells to maintain the latent stage. Studies showed that human coronaviruses (hCoV) activate latent TB to an active state due to unregulated cytokine production, called a cytokine storm. The present review concisely discusses the reason and status of co-infection of COVID-19 with TB based on previous case reports, cohorts, and scientific studies. COVID-19 patients are prone to be infected with TB and vice-versa in TB-prone areas. The therapeutic opportunities for overcoming the COVID-19 induced cytokine storm have also been emphasized by the present clinical trial candidates. In conclusion, we recommend categorizing the patients based on their medical history and cured or latent TB patients should be particularly closely monitored. They should be tested for Interferon Gamma Release Assay (IGRA) regularly on and after COVID-19 infection.